Sialorrhea Treatment Market Top to Bottom Analysis on Growth by 2030

According to our latest study on “Sialorrhea Treatment Market Forecast to 2030 – Global Analysis – by Medical Therapy and End User,” the market was valued at US$ 695.06 million in 2022 and is expected to reach US$ 1,042.37 million by 2030; it is estimated to record a CAGR of 5.2% from 2022 to 2030. The market growth is attributed to the increasing prevalence of neurodegenerative disorders and the availability of various treatment options for sialorrhea. Moreover, rising research and development (R&D) and new drug approvals will likely fuel the sialorrhea treatment market growth in the coming years. However, challenges related to sialorrhea treatment restrain the market growth.

Download Sample PDF Copy @

Sialorrhea Treatment Market Size and Forecast (2020–2030) – Global and Regional Share, Trend, and Growth Opportunity Analysis – by Medical Therapy (Pharmacologic Therapy and Radiotherapy) and End User (Hospitals, Specialty Clinics, Homecare Settings, and Others), and Geography   

Treatments for sialorrhea include behavioral and lifestyle counseling, medication, surgery, and radiation. Nonpharmacological therapies include advice on posture, controlling swallowing, managing cough, dietary adjustments, eating and drinking procedures, and behavioral modification. Nevertheless, these conservative measures might not work for individuals with neurological problems that worsen over time. Many drugs that have been used to treat sialorrhea also have anticholinergic properties that have been utilized to control hypersalivation. Amitriptyline, procyclidine, and rihexyphenidyl are a few of these. Most medications have co-morbidities (such as discomfort or trouble sleeping) and hypersalivation, which makes them potentially helpful in some situations. Therefore, the availability of various treatments for sialorrhea is expected to boost market growth in the coming years.

However, diagnosis and treatment of chronic sialorrhea are delayed due to patient and healthcare professional ignorance about the condition. This is anticipated to be the main obstacle impeding the market expansion for chronic sialorrhea treatments. Furthermore, it is anticipated that healthcare professionals—including specialists and primary care doctors—will know very little about persistent sialorrhea as a separate illness.

About Us:

The Insight Partners is a market research solution and consultation company. Specializing in syndicate market research, our team helps clients in their hunt for revenue pockets in several industries. A team of 250+ research experts is dedicated to offering the most relevant, data-driven, and trustworthy market insights and consultation.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us

The Insight Partners

Phone: +1-646-491-9876

E-mail: [email protected]